Mike Polark
Stock Analyst at Wolfe Research
(3.43)
# 972
Out of 4,984 analysts
75
Total ratings
50%
Success rate
5.8%
Average return
Main Sectors:
Stocks Rated by Mike Polark
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDT Medtronic | Upgrades: Peer Perform | n/a | $94.19 | - | 3 | Jun 30, 2025 | |
| BBNX Beta Bionics | Initiates: Outperform | $20 | $23.29 | -14.13% | 1 | May 30, 2025 | |
| LIVN LivaNova | Upgrades: Outperform | $60 | $54.93 | +9.23% | 9 | May 20, 2025 | |
| PODD Insulet | Upgrades: Outperform | $350 | $332.13 | +5.38% | 4 | May 13, 2025 | |
| INSP Inspire Medical Systems | Maintains: Outperform | $230 → $236 | $80.80 | +192.08% | 7 | May 6, 2025 | |
| IRTC iRhythm Technologies | Maintains: Outperform | $133 → $150 | $174.40 | -13.99% | 8 | May 2, 2025 | |
| KMTS Kestra Medical Technologies | Initiates: Outperform | $29 | $23.20 | +25.00% | 1 | Mar 31, 2025 | |
| EW Edwards Lifesciences | Downgrades: Underperform | $60 | $75.09 | -20.10% | 4 | Jan 16, 2025 | |
| RMD ResMed | Downgrades: Underperform | $180 | $272.60 | -33.97% | 5 | Sep 18, 2024 | |
| ZBH Zimmer Biomet Holdings | Initiates: Peer Perform | n/a | $99.12 | - | 1 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $405 | $376.62 | +7.54% | 1 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $487 → $503 | $434.50 | +15.77% | 7 | Jul 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Peer Perform | n/a | $132.76 | - | 4 | Jul 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $125.82 | - | 3 | Apr 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $121 | $76.55 | +58.07% | 1 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $12.43 | - | 1 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $25 | $16.30 | +53.37% | 4 | Jan 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $165 | $143.43 | +15.04% | 3 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $98.98 | - | 2 | Jul 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $13 | $9.80 | +32.65% | 2 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | $21 | $4.65 | +351.61% | 1 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $230 → $250 | $247.99 | +0.81% | 2 | Aug 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $43 | $1.41 | +2,949.65% | 1 | Sep 2, 2020 |
Medtronic
Jun 30, 2025
Upgrades: Peer Perform
Price Target: n/a
Current: $94.19
Upside: -
Beta Bionics
May 30, 2025
Initiates: Outperform
Price Target: $20
Current: $23.29
Upside: -14.13%
LivaNova
May 20, 2025
Upgrades: Outperform
Price Target: $60
Current: $54.93
Upside: +9.23%
Insulet
May 13, 2025
Upgrades: Outperform
Price Target: $350
Current: $332.13
Upside: +5.38%
Inspire Medical Systems
May 6, 2025
Maintains: Outperform
Price Target: $230 → $236
Current: $80.80
Upside: +192.08%
iRhythm Technologies
May 2, 2025
Maintains: Outperform
Price Target: $133 → $150
Current: $174.40
Upside: -13.99%
Kestra Medical Technologies
Mar 31, 2025
Initiates: Outperform
Price Target: $29
Current: $23.20
Upside: +25.00%
Edwards Lifesciences
Jan 16, 2025
Downgrades: Underperform
Price Target: $60
Current: $75.09
Upside: -20.10%
ResMed
Sep 18, 2024
Downgrades: Underperform
Price Target: $180
Current: $272.60
Upside: -33.97%
Zimmer Biomet Holdings
Sep 10, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $99.12
Upside: -
Sep 10, 2024
Initiates: Outperform
Price Target: $405
Current: $376.62
Upside: +7.54%
Jul 19, 2024
Maintains: Outperform
Price Target: $487 → $503
Current: $434.50
Upside: +15.77%
Jul 21, 2023
Upgrades: Peer Perform
Price Target: n/a
Current: $132.76
Upside: -
Apr 26, 2023
Downgrades: Peer Perform
Price Target: n/a
Current: $125.82
Upside: -
Jan 26, 2023
Initiates: Outperform
Price Target: $121
Current: $76.55
Upside: +58.07%
Jan 26, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $12.43
Upside: -
Jan 11, 2023
Upgrades: Outperform
Price Target: $25
Current: $16.30
Upside: +53.37%
Sep 15, 2022
Upgrades: Outperform
Price Target: $165
Current: $143.43
Upside: +15.04%
Jul 6, 2022
Initiates: Outperform
Price Target: n/a
Current: $98.98
Upside: -
Apr 6, 2022
Initiates: Outperform
Price Target: $13
Current: $9.80
Upside: +32.65%
Apr 6, 2022
Initiates: Peer Perform
Price Target: $21
Current: $4.65
Upside: +351.61%
Aug 11, 2021
Maintains: Outperform
Price Target: $230 → $250
Current: $247.99
Upside: +0.81%
Sep 2, 2020
Initiates: Neutral
Price Target: $43
Current: $1.41
Upside: +2,949.65%